182 related articles for article (PubMed ID: 25360186)
1. Ovarian cancer revealed by paraneoplastic cerebellar degeneration: a case report.
Elomrani F; Ouziane I; Boutayeb S; Bensouda Y; Mrabti H; Errihani H
Pan Afr Med J; 2014; 18():2. PubMed ID: 25360186
[TBL] [Abstract][Full Text] [Related]
2. Ovarian mass Presenting as Paraneoplastic cerebellar degeneration with peripheral neuropathy and anti-Yo antibody.
Sahoo D; Dey A; Dash A; Dash A
BMJ Case Rep; 2024 Jan; 17(1):. PubMed ID: 38272525
[TBL] [Abstract][Full Text] [Related]
3. [Paraneoplastic neurologic degeneration revealing ovarian cancer recurrence].
Zouiten O; Benbrahim Z; Amaadour L; Mellas N
Pan Afr Med J; 2019; 33():281. PubMed ID: 31692829
[TBL] [Abstract][Full Text] [Related]
4. Paraneoplastic cerebellar degeneration associated with anti-Yo antibodies in an ovarian cancer case: A case report.
Deac S; Stana MM; Havasi AD; Cainap C; Popita AR; Bordeianu AM; Cainap S; Bota M; Bochis OV
Gynecol Oncol Rep; 2021 Feb; 35():100695. PubMed ID: 33490355
[TBL] [Abstract][Full Text] [Related]
5. Ovarian cancer and late onset paraneoplastic cerebellar degeneration.
Goldstein BH; Birk CL; Van Houten M; Veve R; Brown JV; Rettenmaier MA; Micha JP
Arch Gynecol Obstet; 2009 Jul; 280(1):99-101. PubMed ID: 18987868
[TBL] [Abstract][Full Text] [Related]
6. Paraneoplastic cerebellar degeneration caused by ovarian clear-cell carcinoma.
Negishi Y; Sakai K; Noguchi Y; Iwasaki N; Kawai N
J Obstet Gynaecol Res; 2014 Feb; 40(2):614-7. PubMed ID: 24148073
[TBL] [Abstract][Full Text] [Related]
7. Anti-Yo paraneoplastic cerebellar degeneration in a patient with stage IV ovarian adenocarcinoma during bevacizumab maintenance therapy.
Giucca A; Morrison H; Wilson T; Cossburn M
BMJ Case Rep; 2023 May; 16(5):. PubMed ID: 37137547
[TBL] [Abstract][Full Text] [Related]
8. Paraneoplastic cerebellar degeneration associated with serous adenocarcinoma of the ovary.
Saeed DB; Gupta L
BMJ Case Rep; 2014 Nov; 2014():. PubMed ID: 25432905
[TBL] [Abstract][Full Text] [Related]
9. Transcriptomic immune profiling of ovarian cancers in paraneoplastic cerebellar degeneration associated with anti-Yo antibodies.
Vialatte de Pémille C; Berzero G; Small M; Psimaras D; Giry M; Daniau M; Sanson M; Delattre JY; Honnorat J; Desestret V; Alentorn A
Br J Cancer; 2018 Jul; 119(1):105-113. PubMed ID: 29899393
[TBL] [Abstract][Full Text] [Related]
10. Genetic alterations and tumor immune attack in Yo paraneoplastic cerebellar degeneration.
Small M; Treilleux I; Couillault C; Pissaloux D; Picard G; Paindavoine S; Attignon V; Wang Q; Rogemond V; Lay S; Ray-Coquard I; Pfisterer J; Joly F; Du Bois A; Psimaras D; Bendriss-Vermare N; Caux C; Dubois B; Honnorat J; Desestret V
Acta Neuropathol; 2018 Apr; 135(4):569-579. PubMed ID: 29299667
[TBL] [Abstract][Full Text] [Related]
11. Anti-Yo positive paraneoplastic cerebellar degeneration associated with ovarian carcinoma: case report and review of the literature.
Cao Y; Abbas J; Wu X; Dooley J; van Amburg AL
Gynecol Oncol; 1999 Oct; 75(1):178-83. PubMed ID: 10502450
[TBL] [Abstract][Full Text] [Related]
12. Paraneoplastic cerebellar degeneration as the first evidence of malignancy: a case report.
Kumari VA; Gupta P; Srivastava MV; Kumar L; Kriplani A; Bhatla N
J Obstet Gynaecol Res; 2014 May; 40(5):1463-5. PubMed ID: 24689522
[TBL] [Abstract][Full Text] [Related]
13. Autopsy findings in the nervous system and ovarian tumour of two patients with paraneoplastic cerebellar degeneration.
Storstein A; Krossnes B; Vedeler CA
Acta Neurol Scand Suppl; 2006; 183():69-70. PubMed ID: 16637935
[TBL] [Abstract][Full Text] [Related]
14. Paraneoplastic cerebellar degeneration mimicking development of secondary progressive multiple sclerosis in a patient with relapsing-remitting multiple sclerosis.
Gracien R; Kordulla M; Ziemann U
Mult Scler; 2011 Apr; 17(4):498-500. PubMed ID: 21148018
[TBL] [Abstract][Full Text] [Related]
15. Two paraneoplastic syndromes in a patient with ovarian cancer: nephrotic syndrome and paraneoplastic cerebellar degeneration.
Forgy AP; Ewing TL; Flaningam J
Gynecol Oncol; 2001 Jan; 80(1):96-8. PubMed ID: 11136578
[TBL] [Abstract][Full Text] [Related]
16. A rare gynecological case of paraneoplastic cerebellar degeneration discovered by FDG-PET.
Marchand V; Graveleau J; Lanctin-Garcia C; Bourbouloux E; Bridji B; Resche I; Kraeber-Bodéré F; Rousseau C
Gynecol Oncol; 2007 May; 105(2):545-7. PubMed ID: 17368524
[TBL] [Abstract][Full Text] [Related]
17. Cerebellar degeneration and ocular myasthenia gravis in a patient with recurring ovarian carcinoma.
Caliandro P; Luigetti M; Ricci E; Mirabella M; Tonali PA; Padua L
Neurol Sci; 2010 Feb; 31(1):79-81. PubMed ID: 19806316
[TBL] [Abstract][Full Text] [Related]
18. Neurologic improvement after high-dose intravenous immunoglobulin therapy in patients with paraneoplastic cerebellar degeneration associated with anti-Purkinje cell antibody.
Phuphanich S; Brock C
J Neurooncol; 2007 Jan; 81(1):67-9. PubMed ID: 16773214
[TBL] [Abstract][Full Text] [Related]
19. Paraneoplastic cerebellar degeneration with anti-Yo antibodies associated with metastatic uveal melanoma.
Valpione S; Zoccarato M; Parrozzani R; Pigozzo J; Giometto B; Laveder F; Aliberti C; Chiarion-Sileni V
J Neurol Sci; 2013 Dec; 335(1-2):210-2. PubMed ID: 24035275
[TBL] [Abstract][Full Text] [Related]
20. Morphological and immunohistochemical characterization of paraneoplastic cerebellar degeneration associated with Yo antibodies.
Storstein A; Krossnes BK; Vedeler CA
Acta Neurol Scand; 2009 Jul; 120(1):64-7. PubMed ID: 19486326
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]